A new treatment could revolutionize the treatment of patients after a heart attack. Hendrik Jan Ankersmit from the Medical University of Vienna has developed a protein solution which can be used to reduce the scarring of tissue caused by inflammation after a heart attack. Read more…
Over the next decade, the population of cancer survivors over 65 years of age will increase by approximately 42 percent. Read more…
The latest results from an expedition to Mount Everest that looked at the body’s response to low oxygen levels suggest that drugs or procedures that promote the body’s production of a chemical compound called nitric oxide (NO) could improve the recovery of critically ill patients in intensive care. Read more…
Civilized human cohabitation requires us to respect elementary social norms. We guarantee compliance with these norms with our willingness to punish norm violations – often even at our own expense. This behavior goes against our own economic self-interest and requires us to control our egoistic impulses. Read more…
A team of scientists led by Dieter Egli and Scott Noggle at The New York Stem Cell Foundation (NYSCF) Laboratory in New York City has made an vital advance in the development of patient-specific stem cells that could impact the study and treatment of diseases such as diabetes, Parkinson’s, and Alzheimer’s. Read more…
Implanted stents can reopen obstructed arteries, but regrowth of cells into the vessel wall can entail restenosis. Research at LMU now shows that an antimicrobial peptide inhibits restenosis and promotes vascular healing. Thus, coating stents with this peptide could increase their clinical efficacy. Read more…
Early detection and diagnosis of open angle glaucoma vital so that treatment can be used in the early stages of the disease developing to prevent or avoid further vision loss. Writing in a forthcoming issue of the International Journal of Medical Engineering and Informatics, researchers in the US have analyzed and ranked the various risk factors for open angle glaucoma so that patients can be screened at an earlier stage if they are more likely to develop the condition. Read more…
A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease. Read more…
A research alliance of Heidelberg University Hospital and the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), jointly with colleagues of the Helmholtz Center for Environmental Research in Leipzig, has learned a new metabolic pathway which makes malignant brain tumors (gliomas) more aggressive and weakens patients’ immune systems. Using drugs to inhibit this metabolic pathway is a new approach in cancer treatment. Read more…
Chagas disease, a tropical parasitic disease that can lead to life-threatening heart and digestive disorders, may be more widespread in Texas than previously thought, according to research from The University of Texas at Austin. Read more…
